• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-127和miR-29在埃及白塞病患者中的表达及其临床意义与疾病活动度的关系

Expression of miR-127 and miR-29 in Egyptian patients with Behçet disease and its clinical significance and relationship with disease activity.

作者信息

Tolba Heba E, Taha Yasser E, Fouad Nermeen A, Abdelaleem Omayma O

机构信息

Department of Rheumatology and Rehabilitation, Faculty of Medicine, Fayoum University, Fayoum, Egypt.

Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Fayoum University, Fayoum, Egypt.

出版信息

Clin Rheumatol. 2025 May 13. doi: 10.1007/s10067-025-07470-4.

DOI:10.1007/s10067-025-07470-4
PMID:40360903
Abstract

BACKGROUND

Behçet's disease (BD) is characterized by a variety of clinical involvements and unpredictable courses of remission and exacerbation. BD cannot be diagnosed based on any particular laboratory, histopathologic, or genetic data. After excluding other possible causes, the diagnosis of BD is mostly made based on clinical manifestations. This research aims to assess the expression of miR-127 and miR-29 in Behçet patients and to correlate this expression with different disease manifestations and disease activity.

METHODS

Seventy adult patients with Behçet disease and 30 matched controls were enlisted. Behçet's Disease Current Activity Form (BDCAF) was used to determine the patients' activity scores. Gene expressions of miR-127 and miR-29 were assessed using real-time PCR.

RESULTS

miR-29 was statistically significantly higher in cases when compared to controls with p < 0.001. Patients with oral ulcers, genital ulcers, and neurological manifestations had a significantly higher levels of miR-29b (p = 0.005, 0.008, 0.003, respectively). Expression level of miR-29b was higher in patients with active disease compared with those who were in inactive state (p = 0.003). Patients with high and moderate severity score had a statistically significant higher expression level of miR-29 when compared to patients with mild severity score. There was a statistically significant positive correlation between miR-29 and several study parameters including BDCAF (r = 0.440, p < 0.001) and severity score (r = 0.243, p = 0.043). miR-127 was statistically significantly lower in cases when compared to controls with p < 0.001. There were statistically significant negative correlations between miR-127 and each of ESR (r = - 0.361, p = 0.002) and BDCAF (r = - 0.350, p = 0.003).

CONCLUSIONS

miR-29 expression level was statistically significantly higher while miR-127 was statistically significantly lower in patients with Behçet disease compared with control individuals. Furthermore, miR-29 was significantly positively correlated whereas miR-127 was significantly negatively correlated with BDCAF denoting their association with disease activity. Key Points • Behçet's disease (BD) is a systemic inflammatory disease with uncertain etiology. There is currently no diagnostic test for Behçet disease. Several miRNAs have been identified as powerful diagnostic biomarkers in many diseases. • Measuring the expression levels of miR-29 and miR-127 in serum of sample of patients with Behçet disease was performed in the current study. • miR-29 expression level was statistically significantly higher while miR-127 was statistically significantly lower in patients with Behçet disease compared with control individuals. Furthermore, miR-29 was significantly positively correlated whereas miR-127 was significantly negatively correlated with BDCAF denoting their association with disease activity.

摘要

背景

白塞病(BD)的特征是有多种临床症状,且缓解和加重过程不可预测。白塞病无法根据任何特定的实验室、组织病理学或基因数据进行诊断。在排除其他可能原因后,白塞病的诊断主要基于临床表现。本研究旨在评估白塞病患者中miR-127和miR-29的表达,并将这种表达与不同的疾病表现和疾病活动度相关联。

方法

招募了70名成年白塞病患者和30名匹配的对照。使用白塞病当前活动形式(BDCAF)来确定患者的活动评分。使用实时PCR评估miR-127和miR-29的基因表达。

结果

与对照组相比,miR-29在病例中的表达在统计学上显著更高,p < 0.001。患有口腔溃疡、生殖器溃疡和神经表现的患者miR-29b水平显著更高(分别为p = 0.005、0.008、0.003)。与处于非活动状态的患者相比,活动期疾病患者的miR-29b表达水平更高(p = 0.003)。与轻度严重程度评分的患者相比,高和中度严重程度评分的患者miR-29的表达水平在统计学上显著更高。miR-29与包括BDCAF(r = 0.440,p < 0.001)和严重程度评分(r = 0.243,p = 0.043)在内的几个研究参数之间存在统计学上显著的正相关。与对照组相比,miR-127在病例中的表达在统计学上显著更低,p < 0.001。miR-127与红细胞沉降率(ESR)(r = -0.361,p = 0.002)和BDCAF(r = -0.350,p = 0.003)中的每一个之间都存在统计学上显著的负相关。

结论

与对照个体相比,白塞病患者中miR-29的表达水平在统计学上显著更高,而miR-127在统计学上显著更低。此外,miR-29与BDCAF呈显著正相关,而miR-127与BDCAF呈显著负相关,表明它们与疾病活动度相关。要点:• 白塞病(BD)是一种病因不明的全身性炎症性疾病。目前尚无白塞病的诊断测试。几种微小RNA(miRNA)已被确定为许多疾病中强大的诊断生物标志物。• 本研究对白塞病患者样本血清中miR-29和miR-127的表达水平进行了测量。• 与对照个体相比,白塞病患者中miR-29的表达水平在统计学上显著更高,而miR-127在统计学上显著更低。此外,miR-29与BDCAF呈显著正相关,而miR-127与BDCAF呈显著负相关,表明它们与疾病活动度相关。

相似文献

1
Expression of miR-127 and miR-29 in Egyptian patients with Behçet disease and its clinical significance and relationship with disease activity.miR-127和miR-29在埃及白塞病患者中的表达及其临床意义与疾病活动度的关系
Clin Rheumatol. 2025 May 13. doi: 10.1007/s10067-025-07470-4.
2
MicroRNA-146a expression and microRNA-146a rs2910164 polymorphism in Behcet's disease patients.miRNA-146a 的表达和 Behcet 病患者中 miRNA-146a rs2910164 多态性。
Clin Rheumatol. 2019 Feb;38(2):397-402. doi: 10.1007/s10067-018-4191-2. Epub 2018 Jul 10.
3
Development of an Arabic version of the Behçet's Disease Current Activity Form (Ar-BDCAF): cross-cultural adaptation and validation initiative in Egypt.《贝切特病活动评估表(Ar-BDCAF)阿拉伯语版本的研制:埃及的跨文化调适和验证研究》
Clin Rheumatol. 2021 Nov;40(11):4609-4618. doi: 10.1007/s10067-021-05817-1. Epub 2021 Jun 25.
4
New insights into the interplay between MALAT1 and miRNA-155 to unravel potential diagnostic and prognostic biomarkers of Behçet's disease.关于MALAT1与miRNA - 155相互作用的新见解,以揭示白塞病潜在的诊断和预后生物标志物。
Clin Rheumatol. 2025 Feb;44(2):775-787. doi: 10.1007/s10067-024-07291-x. Epub 2025 Jan 11.
5
Increased serum interleukin-32 levels in patients with Behçet's disease.白塞病患者血清白细胞介素-32水平升高。
Int J Rheum Dis. 2018 Dec;21(12):2167-2174. doi: 10.1111/1756-185X.13072. Epub 2017 Apr 5.
6
Serum Interleukin-33 in Behcet's Disease: Its Relation to Disease Activity and Clinical Manifestations.白塞病患者血清白细胞介素-33:其与疾病活动度及临床表现的关系
Egypt J Immunol. 2015 Jun;22(2):1-8.
7
The prevalence of fibromyalgia in patients with Behçet's disease and its relation with disease activity.贝赫切特病患者中纤维肌痛的患病率及其与疾病活动的关系。
Rheumatol Int. 2013 May;33(5):1219-22. doi: 10.1007/s00296-012-2530-1. Epub 2012 Sep 28.
8
Interleukin-17 mRNA expression and serum levels in Behçet's disease.白塞病患者白细胞介素-17 mRNA 表达和血清水平。
Cytokine. 2020 Mar;127:154994. doi: 10.1016/j.cyto.2020.154994. Epub 2020 Jan 14.
9
Serum levels of miR-34, miR-182 and miR-378 as novel diagnostic biomarkers in Behçet patients and their relation to disease activity and severity.
Arch Physiol Biochem. 2025 Oct;131(5):753-762. doi: 10.1080/13813455.2025.2497266. Epub 2025 Apr 25.
10
Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?白塞病患者血清基质金属蛋白酶-2和基质金属蛋白酶-9:其较高水平是否与伴有动脉瘤形成的血管性白塞病相关?
Clin Exp Rheumatol. 2007 Jul-Aug;25(4 Suppl 45):S70-5.

本文引用的文献

1
Aberrant miR-29 is a predictive feature of severe phenotypes in pediatric Crohn's disease.异常的 miR-29 是小儿克罗恩病严重表型的预测特征。
JCI Insight. 2024 Feb 22;9(4):e168800. doi: 10.1172/jci.insight.168800.
2
The role of miRNAs in Behçet's disease.miRNAs 在白塞病中的作用。
Front Immunol. 2023 Oct 4;14:1249826. doi: 10.3389/fimmu.2023.1249826. eCollection 2023.
3
The roles of immune cells in Behçet's disease.免疫细胞在白塞病中的作用。
Adv Rheumatol. 2023 Oct 9;63(1):49. doi: 10.1186/s42358-023-00328-w.
4
Update on the Diagnosis of Behçet's Disease.白塞病诊断的最新进展
Diagnostics (Basel). 2022 Dec 23;13(1):41. doi: 10.3390/diagnostics13010041.
5
Behçet's syndrome: one year in review 2022.白塞综合征:2022 年回顾一年。
Clin Exp Rheumatol. 2022 Sep;40(8):1461-1471. doi: 10.55563/clinexprheumatol/h4dkrs. Epub 2022 Jul 26.
6
Downregulation of Renal Hsa-miR-127-3p Contributes to the Overactivation of Type I Interferon Signaling Pathway in the Kidney of Lupus Nephritis.下调肾组织 hsa-miR-127-3p 表达促进狼疮肾炎肾脏中Ⅰ型干扰素信号通路过度激活。
Front Immunol. 2021 Oct 21;12:747616. doi: 10.3389/fimmu.2021.747616. eCollection 2021.
7
MicroRNA regulation of B cell receptor signaling.miRNA 对 B 细胞受体信号的调控。
Immunol Rev. 2021 Nov;304(1):111-125. doi: 10.1111/imr.13024. Epub 2021 Sep 14.
8
MiR-29b-3p promotes particulate matter-induced inflammatory responses by regulating the C1QTNF6/AMPK pathway.miR-29b-3p 通过调控 C1QTNF6/AMPK 通路促进颗粒物诱导的炎症反应。
Aging (Albany NY). 2020 Jan 18;12(2):1141-1158. doi: 10.18632/aging.102672.
9
A Novel Bioengineered miR-127 Prodrug Suppresses the Growth and Metastatic Potential of Triple-Negative Breast Cancer Cells.一种新型 miR-127 前药通过抑制三阴性乳腺癌细胞的生长和转移潜能。
Cancer Res. 2020 Feb 1;80(3):418-429. doi: 10.1158/0008-5472.CAN-19-0656. Epub 2019 Nov 6.
10
TNF-α-elicited miR-29b potentiates resistance to apoptosis in peripheral blood monocytes from patients with rheumatoid arthritis.TNF-α 诱导的 miR-29b 增强类风湿关节炎患者外周血单核细胞对细胞凋亡的抵抗。
Apoptosis. 2019 Dec;24(11-12):892-904. doi: 10.1007/s10495-019-01567-3.